Sarepta Therapeutics, Inc. (SRPT) Operating cash flow 2016–2025
Sarepta Therapeutics, Inc. (SRPT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$205.5MFY2025 · since FY2016: -$245.8M → -$205.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$205.5M | +0.1% |
| FY2024 | -$205.8M | +58.9% |
| FY2023 | -$501.0M | -54.0% |
| FY2022 | -$325.3M | +26.6% |
| FY2021 | -$443.2M | -512.4% |
| FY2020 | $107.5M | +123.5% |
| FY2019 | -$456.5M | -17.4% |
| FY2018 | -$388.7M | -67.5% |
| FY2017 | -$232.0M | +5.6% |
| FY2016 | -$245.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice